Literature DB >> 12461278

Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions initial results.

Kenneth G A Gilhuijs1, Eline E Deurloo, Sara H Muller, Johannes L Peterse, Leo J Schultze Kool.   

Abstract

The authors developed a clinical system for computerized delineation, rating, and classification of breast lesions depicted in contrast material-enhanced magnetic resonance images obtained in women with increased lifetime risk of breast cancer. Initial results showed negative predictive values above 98% at 50% positive predictive value with negligible interoperator differences. The system demonstrated potential to help exclude malignancy with high confidence and reproducibility with a positive predictive value that is acceptable in screening.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461278     DOI: 10.1148/radiol.2253011582

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.

Authors:  Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; Emiel J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2005-11-19       Impact factor: 5.315

Review 2.  Anniversary paper: History and status of CAD and quantitative image analysis: the role of Medical Physics and AAPM.

Authors:  Maryellen L Giger; Heang-Ping Chan; John Boone
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

3.  Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla.

Authors:  Bertine L Stehouwer; Dennis W J Klomp; Maurice A A J van den Bosch; Mies A Korteweg; Kenneth G A Gilhuijs; Arjen J Witkamp; Paul J van Diest; Karel A F Houwert; Wybe J M van der Kemp; Peter R Luijten; W P Th M Mali; Wouter B Veldhuis
Journal:  Eur Radiol       Date:  2013-08-28       Impact factor: 5.315

4.  Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.

Authors:  Akiko Shimauchi; Hiroyuki Abe; David V Schacht; Jian Yulei; Federico D Pineda; Sanaz A Jansen; Rajiv Ganesh; Gillian M Newstead
Journal:  Eur Radiol       Date:  2015-02-20       Impact factor: 5.315

5.  Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.

Authors:  Kenneth E Pengel; Bas B Koolen; Claudette E Loo; Wouter V Vogel; Jelle Wesseling; Esther H Lips; Emiel J Th Rutgers; Renato A Valdés Olmos; Marie Jeanne T F D Vrancken Peeters; Sjoerd Rodenhuis; Kenneth G A Gilhuijs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-29       Impact factor: 9.236

6.  Morphologic blooming in breast MRI as a characterization of margin for discriminating benign from malignant lesions.

Authors:  Alan Penn; Scott Thompson; Rachel Brem; Constance Lehman; Paul Weatherall; Mitchell Schnall; Gillian Newstead; Emily Conant; Susan Ascher; Elizabeth Morris; Etta Pisano
Journal:  Acad Radiol       Date:  2006-11       Impact factor: 3.173

7.  Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.

Authors:  Fijs W B van Leeuwen; Tessa Buckle; Ariena Kersbergen; Sven Rottenberg; Kenneth G A Gilhuijs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-18       Impact factor: 9.236

8.  Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Authors:  Claudette E Loo; Lisanne S Rigter; Kenneth E Pengel; Jelle Wesseling; Sjoerd Rodenhuis; Marie-Jeanne T F D Vrancken Peeters; Karolina Sikorska; Kenneth G A Gilhuijs
Journal:  Breast Cancer Res       Date:  2016-08-05       Impact factor: 6.466

9.  Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Authors:  Alexander M Th Schmitz; Suzana C Teixeira; Kenneth E Pengel; Claudette E Loo; Wouter V Vogel; Jelle Wesseling; Emiel J Th Rutgers; Renato A Valdés Olmos; Gabe S Sonke; Sjoerd Rodenhuis; Marie Jeanne T F D Vrancken Peeters; Kenneth G A Gilhuijs
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

10.  Synchronous Breast Cancer: Phenotypic Similarities on MRI.

Authors:  Hui Wang; Bas H M van der Velden; Hui Shan M Chan; Claudette E Loo; Max A Viergever; Kenneth G A Gilhuijs
Journal:  J Magn Reson Imaging       Date:  2019-12-19       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.